PATENT CLAIM ANALYSIS

Application Number: 16033169
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "275000"]

Abstract:
The applicaton discloses pharmaceutical compounds of formula I useful for treating CNS diseases wherein m, s, R 1 R 5 , R 6  and R 7  are as defined herein.

Claim (Index 1):
A method for treating a central nervous system disease mediated by the 5-HT 6  receptor wherein the disease is selected from the group consisting of state selected from psychoses, schizophrenia, manic depressions, neurological disorders, attention deficit disorder, Parkinson's disease, amyotrophic lateral sclerosis, food uptake disorders, and Huntington's disease, wherein the method comprises administering to said subject in need there a therapeutically effective amount of a compound of formula (I) wherein:\n m is 0 or 1; \n s is 0 to 2; \n R 7  is halo, alkyl, alkoxy, haloalkyl, hydroxy, cyano or methanesulfonyl; \n R 1  is halo; \n one of R 5  and R 6  is hydrogen or alkyl, and other of R 5  and R 6  is hydrogen, alkyl, alkylcarbonyl, alkylsulfonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl or amidinyl; or, \n a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14531465', '11985459', '11315706', '12694033', '11820712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7973498852961334
- 35 USC 102 Novelty (BERT): 0.5222085531061111
- Combined Prediction Score: 0.7698357520771312
- Mean Citation Score: 293.9038280000001
- Max Citation Score: 305.55164
- Similarity Product: 214.6799273206616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test